T1	Participants 129 189	progression of coronary atherosclerosis in diabetic patients
T2	Participants 422 478	favorable effect of pioglitazone on atheroma progression
T3	Participants 491 508	Diabetes mellitus
T4	Participants 571 648	Pioglitazone slowed progression compared with glimepiride in this population.
T5	Participants 665 715	360 diabetic patients with coronary artery disease
T6	Participants 665 686	360 diabetic patients
T7	Participants 2370 2387	diabetic patients
T8	Participants 2479 2525	diabetic patients with coronary artery disease
